Telmisartan in Haemodialysis Patients With Chronic Heart Failure
Effects Of Telmisartan Added To Angiotensin Converting Enzyme Inhibitors On Mortality And Morbidity In Haemodialysed Patients With Chronic Heart Failure: A Double-Blind Placebo-Controlled Trial
Sponsor: University of Campania Luigi Vanvitelli
Listed as NCT00490958, this PHASE4 trial focuses on Heart Failure, Congestive and remains completed. Sponsored by University of Campania Luigi Vanvitelli, it has been updated 6 times since 1999, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Sep 2017 [monthly]
Completed PHASE4
First recorded
Jan 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Campania Luigi Vanvitelli
For direct contact, visit the study record on ClinicalTrials.gov .